[Ip-health] Brief report: UNITAID-Civil Society 1 day consultation, 9th December 2013

Jessica Hamer JHamer at oxfam.org.uk
Thu Mar 6 09:14:44 PST 2014


Brief Report on UNITAID: Civil Society Consultation

9th December 2013, Geneva, Switzerland

UNITAID convened a 1-day consultation with global civil society actors on 
9th December 2013, organised through the UNITAID Board delegation for 
Communities affected by HIV and AIDS, TB and malaria, and the delegation 
for NGOs working in the global response to the three diseases (together 
known as the civil society delegations to UNITAID Board).

UNITAID?s current Strategy (2013-16) articulates the need to build strong 
relationships with civil society, and to encourage civil society 
observation of UNITAID programmes at country level. UNITAID is developing 
a civil society engagement strategy in 2014 to set out how this work will 
be delivered.

The civil society delegations to UNITAID Board saw the consultation as an 
opportunity to look at three priority issues for the delegations. 

1.      Civil society monitoring of UNITAID programmes in-country: To help 
ensure the products UNITAID supports are reaching their intended 
beneficiaries. 
2.      Demand creation for UNITAID-supported health products: The Civil 
Society delegations see a need for UNITAID to support more market 
interventions to create demand for the health products UNITAID funds, (as 
well as its existing work ensuring supply of those products). This would 
involve UNITAID?s investment in civil society advocacy at country level, 
to stimulate demand and encourage country adoption and uptake of these 
products. 
3.      UNITAID?s work on intellectual property: The Civil Society 
delegations were keen to discuss future opportunities for UNITAID to 
expand its work in intellectual property.
A full report on the discussions and recommendations made at the UNITAID: 
Civil Society Consultation is available from the Civil Society 
delegations? Liaison Officer, to all members of the Civil Society 
delegations? Contact Group.

Any representative of a Community affected by HIV/AIDS, TB or malaria, or 
of an NGO working to fight the three diseases, may join the Civil Society 
delegations? to UNITAID Contact Group. Please see the attached Terms of 
Reference, or contact the delegations? Liaison Officer Jessica Hamer (
jhamer at oxfam.org.uk) in order to join the Contact Group, and receive a 
copy of the full delegations? report. 

What is UNITAID?
UNITAID is an innovative global health initiative that uses its long-term 
sustainable funding to support projects that positively impact the market 
for medicines, diagnostics and other health products for HIV/AIDS, TB and 
malaria in developing countries. UNITAID raises money through a 
combination of levies on airline tickets and long-term government funding. 
UNITAID also encourages innovation to ensure medicines are available in 
formulations and combinations that are best suited to the target 
populations and treatment conditions in developing countries. 
What are the Civil Society Delegations?
The UNITAID Board has 12 seats, including one seat for communities 
affected by HIV, TB or malaria, and another seat for NGOs involved in the 
global fight against these diseases. Each board seat allows for one board 
and one alternate board member at the table. Together, the Communities and 
NGOs delegates to the UNITAID Board form the Civil Society Delegations. 
Communities and NGOs Board Members choose to work together a great deal 
but constitute two distinct delegations, each with its own voice and 
strengths.



Jessica Hamer | Liaison Officer, Civil Society Delegations to UNITAID 
Board
+44 (0)1865 473508  | +44 (0) 7879 474766 | skype: jessica.hamer
www.facebook.com/CSDelegationstoUNITAIDBoard 


Oxfam works with others to overcome poverty and suffering.

Oxfam GB is a member of Oxfam International and a company limited by guarantee registered in England No. 612172.
Registered office: Oxfam House, John Smith Drive, Cowley, Oxford, OX4 2JY.
A registered charity in England and Wales (no 202918) and Scotland (SC 039042)



More information about the Ip-health mailing list